Skip to main content
Premium Trial:

Request an Annual Quote

Bill Lundberg

CRISPR Therapeutics announced the appointment of Bill Lundberg as chief scientific officer. Lundberg will lead the firm's development programs and R&D operations in Cambridge, Mass. He comes to CRISPR Therapeutics from Alexion Pharmaceuticals, where he was vice president and head of Translational Medicine. He has also held posts at Taligen Therapeutics, Genzyme, and Wyeth.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.